J. Gascoyne

发表

25‐Hydroxyvitamin D2/D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort

D. Bishop, J. Newton-Bishop, J. Davies, 2015, International journal of cancer.

Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

J. Barrett, R. Thakur, M. Lauss, 2019, Clinical Cancer Research.

β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas

D. Bishop, G. Cook, D. Bishop, 2018, The Journal of clinical investigation.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia

J. Malvehy, S. Puig, J. Barrett, 2014 .

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary cancer in clinical practice.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary Cancer in Clinical Practice.

Frequency of familial colorectal cancer

D. Bishop, P. Finan, J. Gascoyne, 1991, The British journal of surgery.

Transcriptomic classification of primary melanoma reveals 1 molecular signatures which add prognostic value to 2 current staging systems including stage I disease 3

D. Bishop, R. Thakur, M. Lauss, 2020 .

Transcriptomic analysis reveals prognostic molecular 1 signatures of stage I melanoma 2

D. Bishop, R. Thakur, M. Lauss, 2019 .

Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

Geoffrey S. Tobias, K. Nielsen, J. Malvehy, 2017, Nature Communications.

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK

J. Barrett, D. Bishop, G. Giles, 2011, Journal of Medical Genetics.